PIII, TRT, and SLE rally sharply after reporting better-than-expected earnings and operational improvements amid broader market volatility.
P3 Health Partners (PIII) soared 180% after reporting Q1 EPS of $0.32, beating consensus estimates of -$3.50, and swinging to a $3.04M net income from a $44.25M loss. The company also raised its FY2026 adjusted EBITDA guidance to a $40M midpoint, citing expanded medical margins of $73.66M.
Trio-Tech International (TRT) jumped 43% on fiscal Q3 revenue of $16.51M, up 123.6% year-over-year, driven by $7.8M in cumulative Burn-In Board orders for AI GPU platforms. Its Semiconductor Back-End Solutions segment surged 141%. Super League Enterprise (SLE) climbed 48% after posting Q4 2025 EPS of -$0.96, better than the -$2.88 consensus, and ended the year debt-free with $14.39M in cash.
The gains followed a shift in market sentiment as traders rotated into micro-cap stocks with operational catalysts, overshadowing broader volatility triggered by external remarks.